Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) Director Stephen P. Mawer sold 3,655 shares of the firm's stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $12.88, for a total value of $47,076.40. Following the completion of the transaction, the director now directly owns 287,307 shares in the company, valued at $3,700,514.16. This trade represents a 1.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Calumet Specialty Products Partners Price Performance
Calumet Specialty Products Partners stock opened at $12.23 on Thursday. Calumet Specialty Products Partners, L.P. has a 1 year low of $9.97 and a 1 year high of $25.29. The firm's 50 day moving average price is $14.92 and its 200-day moving average price is $18.50. The stock has a market cap of $1.05 billion, a P/E ratio of -4.43 and a beta of 1.88.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million during the quarter, compared to the consensus estimate of $921.76 million. During the same quarter in the prior year, the firm posted ($0.59) earnings per share. The business's revenue was down 2.8% on a year-over-year basis. As a group, equities analysts expect that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on CLMT shares. UBS Group raised shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and reduced their target price for the stock from $15.00 to $12.00 in a report on Monday, March 17th. HC Wainwright reissued a "buy" rating and issued a $33.00 price objective on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. TD Cowen cut shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their target price for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. Finally, Wells Fargo & Company cut their price target on Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a research note on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, Calumet Specialty Products Partners presently has an average rating of "Hold" and a consensus target price of $20.80.
View Our Latest Report on CLMT
Calumet Specialty Products Partners Company Profile
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
